Assessment of hematological and immunological function during long-term follow-up after peripheral blood stem cell transplantation

Haematologica

Volumn 83, Issue 2, 1998, Pages 138-142

  Laurenti, Luca ^a   Sica, Simona ^a   Salutari, Prassede ^a   Rutella, Sergio ^a   Serafini, Riccardo ^a   D'Onofrio, Giuseppe ^a   Rumi, Carlo ^a   Leone, Giuseppe ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Hematological reconstitution; Immune recovery; Myelodysplasia post transplant; PBPC transplantation

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; LONG TERM CARE; MALE; PERIPHERAL BLOOD STEM CELL; REMISSION; STEM CELL TRANSPLANTATION;

ADULT; ANTIGENS, CD19; ANTIGENS, CD3; ANTIGENS, CD4; ANTIGENS, CD8; BONE MARROW CELLS; CD4-CD8 RATIO; ERYTHROCYTE INDICES; FEMALE; FOLLOW-UP STUDIES; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; KILLER CELLS, NATURAL; LEUKOCYTE COUNT; LYMPHOCYTES; MALE; MIDDLE AGED; PLATELET COUNT; RETICULOCYTE COUNT; TIME FACTORS; TRANSPLANTATION CONDITIONING;

EID: 0031916451     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Carlo-Stella C, Tabilio A. Stem cells and stem cell transplantation. Haematologica 1996; 81:573-87.
2. Abrams RA, Glaubiger D, Appelbaum FR, Deiss-roth AB. Results of attempted hemopoietic reconstitution using isologous, peripheral blood mononuclear cells: a case report. Blood 1980; 56:516.
3. Juttner CA, To LB, Haylock DN, Brandford A, Kimber RJ. Circulating autologous stem cells collected in very early remission from acute non-lymphoblastic leukemia produces prompt but incomplete hemopoietic reconstitution after high dose melphalan or supralethal chemoradiotherapy. Br J Haematol 1985; 61:739-45.
4. Rossi A, Cortellazzo S, Bellavita P, et al. Long-term haematological reconstitution following BEAM and autologous transplantation of circulating progenitor cells in non-Hodgkin's lymphoma. Br J Haematol 1997; 96:620-6.
5. + progenitor cell (PBPC) transplantation: a flow cytometric study [abstract]. Exp Hematol 1995; 23:51a.
6. Bennett JM, Catovsky D, Daniel MT, et al (FAB Cooperative Group). Proposal for the classification of the myelodysplastic syndromes. Br J Haematol 1982; 51:189-99.
7. Miller JS, Arthur DC, Litz CE, Neglia JP, Miller WJ, Weeisdorf DJ. Myelodysplastic syndrome after autologous bone marrow transplantation: an additional late complication of curative cancer therapy. Blood 1994; 83:3780-6.
8. Stone RM. Myelodysplastic syndrome after autologous transplantation for lymphoma: The price of the progress? [editorial]. Blood 1994; 83:3437-40.
9. Koehne G, Zeller W, Stockschlaeder M, Zander AR. Phenotype of lymphocyte subsets after autologous peripheral blood stem cell transplantation. Bone Marrow Transpl 1997; 19:149-56.
10. + T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med 1995; 19:143-9.
11. + T cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy. Blood 1997; 89:3700-7.
12. Dulude G, Brochu S, Fontaine P, et al. Thymic and extrathymic differentiation and expansion of T lymphocytes following bone marrow transplantation in irradiated recipients. Exp Hematol 1997; 25:992-1004.
13. Henon PR, Liang H, Beck-Wirth G, et al. Comparison of hematopoietic and immune recovery after autologous bone marrow or blood stem cell transplants. Bone Marrow Transpl 1992; 9:285-91.
14. Rosillo MC, Ortuño F, Moraleda JM, et al. Immune recovery after autologous or rhG-CSF primed PBSC transplantation. EurJ Haematol 1996; 56:301-7.